Integer Holdings Corporation (NYSE:ITGR – Get Free Report) insider Kirk Thor sold 11,767 shares of Integer stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the transaction, the insider directly owned 7,153 shares in the company, valued at approximately $902,923.19. This represents a 62.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Integer Price Performance
ITGR opened at $126.22 on Thursday. The company has a quick ratio of 2.41, a current ratio of 3.73 and a debt-to-equity ratio of 0.75. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $126.79. The company has a fifty day simple moving average of $116.25 and a 200 day simple moving average of $98.19. The stock has a market cap of $4.29 billion, a P/E ratio of 34.49, a P/E/G ratio of 2.40 and a beta of 0.62.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping the consensus estimate of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm’s revenue was down 2.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.55 EPS. On average, research analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current year.
Hedge Funds Weigh In On Integer
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on ITGR. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Truist Financial cut Integer from a “buy” rating to a “hold” rating and increased their target price for the stock from $110.00 to $127.00 in a research note on Monday, August 3rd. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Benchmark downgraded shares of Integer from a “buy” rating to a “hold” rating in a report on Thursday, August 13th. Finally, Piper Sandler lowered shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target on the stock. in a research note on Monday, August 3rd. One analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. Based on data from MarketBeat, Integer has a consensus rating of “Hold” and a consensus target price of $109.86.
Check Out Our Latest Analysis on Integer
About Integer
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
Further Reading
- Five stocks we like better than Integer
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
